Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics:
- Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Cancer (UBC) (0:00)
- Systemic Therapy for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer (MIBC) (13:35)
- Evolving Approach to Systemic Therapy for Cisplatin-Ineligible Patients with MIBC (37:13)
- Immune Checkpoint Inhibitors in Non-Muscle-Invasive Bladder Cancer (58:55)
- Novel Intravesical Therapies for Nonmetastatic UBC (1:10:20)